IL SB1842

Requires opioid treatment programs licensed by the Department of Human Services to report controlled substance dispensing data to the Prescription Monitoring Program, following a 2020 federal rule change (42 CFR 2) that now permits such information sharing

Opioid treatment programs must obtain written patient consent before transmitting information to the Prescription Monitoring Program and cannot condition treatment on whether consent is provided

Raises the threshold for triggering medication shopping alerts from 3 or more prescribers/pharmacies within 30 days to 5 or more prescribers/pharmacies within a 6-month period

Changes the reporting deadline for dispensers to submit controlled substance information to the Prescription Monitoring Program from "the next business day after" dispensing to "the business day on which" the substance is dispensed

Requires designees who access the Prescription Monitoring Program on behalf of prescribers or pharmacists to receive training in both HIPAA and 42 CFR 2 (substance use disorder patient record confidentiality regulations)